日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours

甲氨蝶呤高剂量给药治疗婴幼儿恶性脑肿瘤的药代动力学基础

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.14160
Panetta, John C; Roberts, Jessica K; Huang, Jie; Lin, Tong; Daryani, Vinay M; Harstead, K Elaine; Patel, Yogesh T; Onar-Thomas, Arzu; Campagne, Olivia; Ward, Deborah A; Broniscer, Alberto; Robinson, Giles; Gajjar, Amar; Stewart, Clinton F
肿瘤
肿瘤免疫
神经科学
发表日期：2020
文献求助 收藏

Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature

中枢神经系统肿瘤抗癌药物的药代动力学特性：文献更新

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-015-0319-6
Jacus, Megan O; Daryani, Vinay M; Harstead, K Elaine; Patel, Yogesh T; Throm, Stacy L; Stewart, Clinton F
肿瘤
肿瘤免疫
神经科学
发表日期：2016
文献求助 收藏

Determination of Methotrexate, 7-Hydroxymethotrexate, and 2,4-Diamino-N10-methylpteroic Acid by LC-MS/MS in Plasma and Cerebrospinal Fluid and Application in a Pharmacokinetic Analysis of High-Dose Methotrexate

通过 LC-MS/MS 测定血浆和脑脊液中的甲氨蝶呤、7-羟基甲氨蝶呤和 2,4-二氨基-N10-甲基蝶酸，并应用于高剂量甲氨蝶呤的药代动力学分析

期刊:Journal of Liquid Chromatography & Related Technologies
影响因子:1
doi:10.1080/10826076.2016.1243558
Michael S Roberts, Nicholas S Selvo, Jessica K Roberts, Vinay M Daryani, Thandranese S Owens, K Elaine Harstead, Amar Gajjar, Clinton F Stewart
信号转导
发表日期：2016
文献求助 收藏

P-glycoprotein, but not multidrug resistance protein 4, plays a role in the systemic clearance of irinotecan and SN-38 in mice

P-糖蛋白（而非多药耐药蛋白4）在小鼠体内伊立替康和SN-38的全身清除中发挥作用。

期刊:Drug Metabolism Letters
影响因子:
doi:10.2174/187231210792928251
Tagen, Michael; Zhuang, Yanli; Zhang, Fan; Harstead, K Elaine; Shen, Jun; Schaiquevich, Paula; Fraga, Charles H; Panetta, John C; Waters, Christopher M; Stewart, Clinton F
发表日期：2010
文献求助 收藏